Primerica's Q2 2022 results showed a mixed performance. While total revenues increased by 2%, net income and EPS decreased by 16% and 13%, respectively. The Term Life segment remained strong, but the Investment and Savings segment was impacted by market correction. The company is focusing on sales force momentum and anticipates a better second half of the year.
New life licenses increased by 14%, driving the sales force to 132,149 representatives.
Term Life net premiums increased by 7%, with adjusted direct premiums increasing by 8%.
Investment and Savings Products sales reached $2.7 billion, with net client inflows of $0.9 billion.
Net earnings per diluted share (EPS) of $2.79 declined 13%, and return on stockholders’ equity (ROE) was 23.3%.
Primerica is encouraged by the momentum in its sales force and expects benefits from improvements in the licensing process and excitement generated during the convention. The company believes it is well-positioned for the second half of the year.
Visualization of income flow from segment revenue to net income